• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Abivax SA - American Depositary Shares (NQ:ABVX)

    116.21 -3.95 (-3.29%)
    Streaming Delayed Price Updated: 2:51 PM EDT, Apr 20, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 528,393
    Open 120.21
    Bid (Size) 116.21 (100)
    Ask (Size) 116.32 (300)
    Prev. Close 120.16
    Today's Range 116.17 - 120.75
    52wk Range 5.590 - 148.83
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    This Beaten-Down Drug Stock Is Down Over 10% -- Is It Finally a Buy? ↗
    We'll soon know more about the drugmaker's long-term prospects. 
    Via The Motley Fool
    News headline image
    Abivax Publishes Financial Reports with the French and U.S. Securities Regulatory Agencies
    From Abivax
    Via GlobeNewswire

    Performance

    YTD
    -13.1%
    -13.1%
    1 Month
    -3.4%
    -3.4%
    3 Month
    -2.2%
    -2.2%
    6 Month
    +27.0%
    +27.0%
    1 Year
    +1765.3%
    +1765.3%

    More News

    Read More
    News headline image
    2 Healthcare Stocks That Could Soar Over the Next 5 Years ↗
    Via The Motley Fool
    News headline image
    Abivax Announces Full Year 2025 Financial Results and Provides Business Updates
    From Abivax
    Via GlobeNewswire
    News headline image
    Goldman Sachs Bullish Forecast: 15% Increase in 2026 U.S. M&A Activity
    Via MarketMinute
    Topics Artificial Intelligence Economy Intellectual Property
    News headline image
    2 Healthcare Stocks to Buy Before They Get Bought Out ↗
    Via The Motley Fool
    News headline image
    This Investor Sold $104 Million of Nuvalent Stock Amid Cancer Drug Developer's Nearly 30% Rally ↗
    Via The Motley Fool
    News headline image
    This Biotech Attracted a $181 Million Investment During a Staggering 1,300% Stock Rally ↗
    Via The Motley Fool
    News headline image
    This Fund Bought $28 Million of a Beaten-Down Immunotherapy Stock Last Quarter. What Should Long-Term Investors Know? ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    This $64 Million Biotech Exit Seemingly Missed a 77% One-Day Surge on Gilead Takeover Deal ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Biotech Stock Up Nearly 300% Draws $68.7 Million Bet as Breast Cancer Drug Targets 2027 Launch ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    This Biotech Stock Up 700% Is Still a Top Holding Despite a $9.3 Million Sale Last Quarter ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    What to Know About This Obesity Drug Developer That Just Drew a New $7 Million Investment ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    This Biotech With a Breakout MS Drug Draws $8 Million Investment Amid 30% Stock Drop ↗
    Via The Motley Fool
    News headline image
    This Biotech Stock Surged 75% Last Quarter and Pulled a New $9 Million Investment ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    This Life Sciences Supplier Has Plunged 50% in a Year, but One Fund Bought Up $28 Million More in Stock ↗
    Via The Motley Fool
    Topics Regulatory Compliance Supply Chain
    News headline image
    Billionaire Steve Cohen Owns Shares of This Stock That Has Soared 1,600% in The Past Year ↗
    Via The Motley Fool
    News headline image
    2 Reasons Abivax Stock Could 10X by 2036 ↗
    Via The Motley Fool
    News headline image
    Abivax Presents First Evidence of Anti-Fibrotic Activity for Obefazimod Alongside New Clinical Efficacy and Safety Analyses in Inflammatory Bowel Disease at ECCO 2026
    From Abivax
    Via GlobeNewswire
    News headline image
    Biotech Exit: $26 Million Arcellx Sale Follows Tepid Stock Performance and Kelonia Competition ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Cogent Biosciences Stock Up 346% as Fund Builds $29 Million Stake After November Phase 3 Breakthrough ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Fund Discloses $35 Million Biotech Buy Amid Staggering 830% Terns Stock Surge ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Biotech Stock Up 266%: This New $55 Million Bet Signals Conviction in Praxis Amid Pipeline Progress ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Apogee Stock Jumps 87% in One Year as This Biotech Fund Lifts Stake to $93 Million ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Missed Out on Eli Lilly? 2 Healthcare Stocks With Big Catalysts on the Horizon. ↗
    Via The Motley Fool

    Frequently Asked Questions

    Is Abivax SA - American Depositary Shares publicly traded?
    Yes, Abivax SA - American Depositary Shares is publicly traded.
    What exchange does Abivax SA - American Depositary Shares trade on?
    Abivax SA - American Depositary Shares trades on the Nasdaq Stock Market
    What is the ticker symbol for Abivax SA - American Depositary Shares?
    The ticker symbol for Abivax SA - American Depositary Shares is ABVX on the Nasdaq Stock Market
    What is the current price of Abivax SA - American Depositary Shares?
    The current price of Abivax SA - American Depositary Shares is 116.21
    When was Abivax SA - American Depositary Shares last traded?
    The last trade of Abivax SA - American Depositary Shares was at 04/20/26 02:51 PM ET
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.